A More Long-Term View on Biotech ETFs

The biotech sector is pulling back, but new breakthroughs and the aging demographics could continue to support gains in biotechnology exchange traded funds. Biotech stocks have dipped over the past week after posting robust gains. Over the past week, the iShares Nasdaq Biotechnology ETF (NasdaqGS:...